相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Endostar (rh-endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non-small cell lung cancer: A meta-analysis
Jihong An et al.
THORACIC CANCER (2018)
Chemotherapy with gemcitabine plus cisplatin in patients with advanced thymic squamous cell carcinoma: Evaluation of efficacy and toxicity
Yang Luo et al.
THORACIC CANCER (2016)
ERCC5 variant rs2296147 T-allele creates a predicted TP53 binding site and up-regulates transcript abundance in normal bronchial epithelial cells, while rs17655 C-allele is linked to miRNA binding site variant and down regulates
Xiaolu Zhang et al.
CANCER RESEARCH (2016)
Are Anthracycline-Based Regimens Truly Indicated To Be the Standard Chemotherapy Regimen for Thymic Carcinoma?
Fumihiko Hirai et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Efficacy and safety of extended use of platinum-based doublet chemotherapy plus endostatin in patients with advanced nonsmall cell lung cancer
Weiheng Hu et al.
MEDICINE (2016)
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
Anish Thomas et al.
LANCET ONCOLOGY (2015)
A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L
F. Hirai et al.
ANNALS OF ONCOLOGY (2015)
Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy
Yusuke Okuma et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial
Giovannella Palmieri et al.
FUTURE ONCOLOGY (2014)
Phase II Study of Amrubicin Combined with Carboplatin for Thymic Carcinoma and Invasive Thymoma North Japan Lung Cancer Group Study 0803
Akira Inoue et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Rare thoracic cancers, including peritoneum mesothelioma
Sabine Siesling et al.
EUROPEAN JOURNAL OF CANCER (2012)
Predictive value of circulating endothelial cells for efficacy of chemotherapy with Rh-endostatin in non-small cell lung cancer
Zhu-Jun Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Rare cancers are not so rare: The rare cancer burden in Europe
Gemma Gatta et al.
EUROPEAN JOURNAL OF CANCER (2011)
Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma
Girum L. Lemma et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
Alfonso Duenas-Gonzalez et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Long-term-survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer (vol 17, pg v118, 2006)
Hans von der Maase et al.
ANNALS OF ONCOLOGY (2011)
Epidemiology of Thymoma and Associated Malignancies
Eric A. Engels
JOURNAL OF THORACIC ONCOLOGY (2010)
Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus
Anca Maria Cimpean et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2008)
Thymic epithelial turnours: A population-based study of the incidence, diagnostic procedures and therapy
Wouter K. de Jong et al.
EUROPEAN JOURNAL OF CANCER (2008)
Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells
Yun Ling et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Long-term-survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer
H von der Maase et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Thymic carcinoma presenting as cranial metastasis with intradural and extracranial extension: Case report
Y Tamura et al.
NEUROSURGERY (2004)
Chemotherapy for advanced thymic carcinoma - Clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy)
T Koizumi et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer
V Heinemann et al.
ANNALS OF ONCOLOGY (2000)
分享论文
